Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...

This puts it ahead of rivals Bayer and the GSK-Novartis joint venture, even though Boehringer has held on to its China consumer health business; the German company knows this is one of the best ...

Boehringer Ingelheim has signed a contract with US digital health management company ... it will be expanded to encompass up to one thousand patients in different countries.

Learn how turkey producers in the U.S. will soon be able to vaccinate their birds to prevent the highly contagious disease.

Boehringer Ingelheim India has signed a Memorandum of Understanding (MoU) with Hyderabad-based EMRI Green Health Services a ...